Clinical trial
Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
NCT05813899 is registered in ClinicalTrials.gov with Mackay Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome
- Lead sponsor
- Mackay Memorial Hospital
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 16, 2023
- Completion date
- April 30, 2024
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-covid-19 syndrome